Virus
Novel H1N1 Influenza
search
Novel H1N1 Influenza
, H1N1 Novel Influenza
See Also
Influenza
Definitions
Influenza
-Like Illness (ILI)
Documented fever >37.8 C. or (>100 F) and-or
Cough
and
Sore Throat
Absence of another cause
Epidemiology
Reported
Apri
l 12, 2009 in Veracruz, Mexico and WHO declared pandemic by
Apri
l 27, 2009
(2009) N Engl J Med 361:674-9 [PubMed]
Widespread
Influenza
in United States in September, 2009
Peak this early is unprecedented (previously outbreaks started in October and November)
Global pandemic declared over as of August 2010
United States H1N1 outcomes
Cases: 61 million infected
Hospitalizations: 274,000
Deaths: 12,470
Pathophysiology
Chimera of swine flu, avian flu, and human flu
Transmission through respiratory droplets (coughing, sneezing, or contaminated fomites)
Labs
Standard rapid
Influenza
A and B testing only has 70%
Test Sensitivity
at best
Treat outpatient cases empirically without testing
Hospitalized case testing
Test with
Rapid Influenza Test
ing and
Viral culture and
Send sample to Department of Public Health (process varies by state)
Management
Indications to use specific agents (e.g.
Tamiflu
) as soon as possible (do not wait for labs)
All patients hospitalized for
Influenza
-like illness
Patients at high risk of complication from
Influenza
-like illness
Prophlyaxis for patients at high risk of complication with close exposure to contact with H1N1
Use treatment protocol instead of prophylaxis if exposure was >48 hours ago
Do not give prophylaxis to healthy patients without risk
Treatment and prophylaxis may be started by phone for patients who meet criteria
Quarantine
Stay home for 7 days from onset or at least 24 after last fever, significant symptoms
Prevention
H1N1
Immunization
Prevent transmission
Isolate patient early in triage process and have them wear mask
Modified Droplet Precautions
Healthcare workers wear mask with shield, gloves, gown
N95 required only for aerosol generating procedure (e.g. intubation), but not nebulizer
Pregnant healthcare workers should not take care of H1N1 patients
Patients should still be considered infectious even after completing
Antiviral Agent
s (i.e
Tamiflu
)
Prognosis
Risks of mortality
Highest risk ages
Under age 5 years (especially under age 1 years)
Age 45-54 years old
Pregnant women (highest risk in third trimester)
Corticosteroid
use has been associated with a higher mortality risk
References
Kline (2009) UMN CME Internal Medicine Review, Minneapolis
Type your search phrase here